US Broker Ratings

Masimo Corporation (MASI) Stock Analysis: Navigating Growth with a $9.51 Billion Market Cap and Strategic Healthcare Innovations

Masimo Corporation (MASI), a prominent player in the healthcare sector with a specific focus on medical devices, continues to carve out its niche in the industry. With a market capitalization..

Alnylam Pharmaceuticals, Inc. (ALNY)

⚠️ No article content returned.

..

AstraZeneca PLC (AZN) Stock Analysis: Navigating Potential 10.68% Upside Amid Strategic Growth

AstraZeneca PLC (AZN), a leading player in the global healthcare sector, presents an intriguing investment opportunity for those looking to navigate the dynamic world of pharmaceuticals. With a robust market..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Healthcare Giant Offers 44% Upside Potential for Investors

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, stands out as a compelling investment opportunity for those looking to..

Halozyme Therapeutics, Inc. (HALO): Consensus Overview and Growth Potential with a 37% Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO) presents an intriguing opportunity for investors in the healthcare sector, particularly within biotechnology. The company, with a robust market capitalization of $7.3 billion, stands at..

Illumina, Inc. (ILMN) Stock Analysis: A Healthcare Giant with a 15.67% Potential Upside

Investors with an eye on the healthcare sector might find Illumina, Inc. (NASDAQ: ILMN) a compelling opportunity. As a leader in the diagnostics and research industry, Illumina is renowned for..

The Cooper Companies, Inc. (COO)

⚠️ No article content returned.

..

Insmed Incorporated (INSM) Stock Analysis: Unveiling a Promising 46.7% Upside in the Biotech Sector

For investors with a keen eye on the biotechnology sector, Insmed Incorporated (NASDAQ: INSM) presents an intriguing opportunity. As a company at the forefront of developing therapies for serious and..

Waystar Holding Corp. (WAY) Stock Analysis: A 56% Potential Upside in Healthcare Tech

Waystar Holding Corp. (NASDAQ: WAY), a leader in health information services, is drawing significant attention from investors with its compelling growth narrative and substantial upside potential. As a company that..

Genmab A/S (GMAB) Stock Analysis: Unveiling a 43.83% Potential Upside in the Biotech Sector

Genmab A/S (GMAB), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline and robust collaborations. Headquartered in Copenhagen, Denmark, Genmab is renowned for developing..

Centene Corporation (CNC) Stock Analysis: A 34.93% Upside Potential in the Healthcare Sector

Centene Corporation (NYSE: CNC) stands as a formidable player in the healthcare sector, focusing on managed care services for under-insured families and commercial organizations in the United States. With a..

Tenet Healthcare Corporation (THC) Stock Analysis: A 36% Growth Potential in the Healthcare Sector

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the healthcare sector, is catching the eye of investors with its substantial growth potential. With a market capitalization of $16.86 billion,..

Sanofi (SNY) Stock Analysis: Evaluating the 23.3% Potential Upside

Sanofi (SNY), a heavyweight in the healthcare sector and a stalwart in the global pharmaceutical industry, presents a compelling investment opportunity with a notable potential upside of 23.3%. Headquartered in..

Labcorp Holdings Inc. (LH) Stock Analysis: Exploring 16.47% Potential Upside in the Healthcare Diagnostics Sector

Labcorp Holdings Inc. (NYSE: LH) stands as a prominent player in the healthcare diagnostics and research industry with a market capitalization of $21.9 billion. Based in Burlington, North Carolina, Labcorp..

DexCom, Inc. (DXCM) Investor Outlook: Navigating a 39.96% Potential Upside in the Healthcare Sector

DexCom, Inc. (NASDAQ: DXCM), a prominent player in the medical devices industry, stands out with its focus on continuous glucose monitoring (CGM) systems. With a market capitalization of $24.28 billion,..

Tempus AI, Inc. (TEM) Stock Analysis: Eyeing a 76.98% Upside Potential Amidst Robust Revenue Growth

Tempus AI, Inc. (NASDAQ: TEM), a key player in the healthcare technology sector, is drawing significant attention from investors, thanks to its potential upside of 76.98% and remarkable revenue growth..

Avantor, Inc. (AVTR)

⚠️ No article content returned.

..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 66.93% Potential Upside

Doximity, Inc. (NYSE: DOCS), a leading digital platform for medical professionals, has been gaining attention in the healthcare sector. With its innovative approach to connecting healthcare providers, Doximity offers a..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Discovering Growth Opportunities with a Solid Dividend Yield

Takeda Pharmaceutical Company Limited (NYSE: TAK) presents itself as a promising investment opportunity, particularly for those interested in the healthcare sector. Based in Tokyo, Japan, Takeda is a global leader..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Strong Buy Ratings and 31.59% Potential Upside

Teva Pharmaceutical Industries Limited (NYSE: TEVA), a leading player in the healthcare sector specializing in both specialty and generic drug manufacturing, continues to capture investor attention with its promising potential..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds